MEMENTO: A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Sep 17, 2026 - P4 | N=63 | Active, not recruiting | Sponsor: Bristol-Myers Squibb | Trial completion date: Jul 2026 ➔ Jun 2027
Trial completion date • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Obstructive Hypertrophic Cardiomyopathy
|